EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
1 clinical trials · Condition
◉ Watch EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
| Record | Firm | Date |
|---|---|---|
| ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma (NCT04245085) | ETOP IBCSG Partners Foundation | 2020-09-29 |
Track EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.